Back to Search
Start Over
Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes
- Source :
- Alves de Inda , M , van Strijp , D , den Biezen-Timmermans , E , van Brussel , A , Wrobel , J , van Zon , H , Vos , P , Baillie , GS , Tennstedt , P , Schlomm , T , Houslay , MD , Bangma , C H & Hoffmann , R 2018 , ' Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes ' , European Urology Focus , vol. 4 , no. 3 , pp. 376-384 .
- Publication Year :
- 2018
Details
- Database :
- OAIster
- Journal :
- Alves de Inda , M , van Strijp , D , den Biezen-Timmermans , E , van Brussel , A , Wrobel , J , van Zon , H , Vos , P , Baillie , GS , Tennstedt , P , Schlomm , T , Houslay , MD , Bangma , C H & Hoffmann , R 2018 , ' Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes ' , European Urology Focus , vol. 4 , no. 3 , pp. 376-384 .
- Notes :
- application/pdf, und
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1313624900
- Document Type :
- Electronic Resource